Gemcitabine, Oxaliplatin and Capecitabine (GEMOXEL) for Patients With Advanced Pancreatic Adenocarcinoma (APC): A Phase I/II Study.
Phase of Trial: Phase I/II
Latest Information Update: 13 Jan 2010
At a glance
- Drugs Capecitabine; Gemcitabine; Oxaliplatin
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 13 Jan 2010 Actual end date (1 Dec 2009) added as reported by ClinicalTrials.gov.
- 13 Jan 2010 Actual patient number (46) added as reported by ClinicalTrials.gov.
- 13 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.